Ufp Technologies INC

Market Movers (8-K)

See all →
NASDAQ
UFP Technologies announced record-breaking second quarter financial results, driven by a 15.1% increase in net sales to $174.0 million and a 21.4% rise in net income to $20.9 million.
Delay expected
Better than expected
NASDAQ
UFP Technologies announced the appointment of Ryan Stafford as General Counsel and Senior Vice President of Human Resources, effective June 4, 2026, succeeding the retiring Christopher P. Litterio.
NASDAQ
UFP Technologies releases updated investor presentation highlighting its growth strategy and financial performance in the medical device manufacturing sector.
NASDAQ
UFP Technologies, Inc. successfully concluded its 2026 Annual Meeting of Stockholders, confirming the election of seven directors and the ratification of its independent auditor.
NASDAQ
UFP Technologies announces the planned retirement of its General Counsel, Secretary, and Senior Vice President of Human Resources.
NASDAQ
UFP Technologies announced first quarter 2026 financial results, with net income rising 1.8% to $17.5 million and net sales increasing 4.1% to $154.2 million, driven by medical device segment growth.

Quarterly Earnings (10-Q)

See all →
NASDAQ
UFP Technologies announced a 15.1% increase in net sales for Q2 2026, driven by growth in key medical sub-markets and improved operating efficiencies.
Better than expected
NASDAQ
UFP Technologies reported a 4.1% increase in net sales to $154.2 million for the first quarter of 2026, driven by growth in the medical device market.
NASDAQ
UFP Technologies reports a 6.5% increase in Q3 net sales to $154.6 million, primarily driven by recent acquisitions, despite labor inefficiencies impacting organic growth.
Worse than expected
Capital raise
Delay expected
NASDAQ
UFP Technologies announced significant revenue and net income increases for Q2 2025, primarily fueled by recent strategic acquisitions in the medical market, despite some gross margin compression.
Capital raise
NASDAQ
UFP Technologies' Q1 2025 net sales increased by 41.1% year-over-year, primarily driven by growth in the medical market and contributions from recent acquisitions.
Better than expected
NASDAQ
UFP Technologies' Q3 2024 results show significant growth in net sales and operating income, primarily driven by recent acquisitions and organic growth in the medical market.
Better than expected

Annual Reports (10-K)

NASDAQ
UFP Technologies, a contract development and manufacturing organization, reported a 19.5% increase in net sales to $602.8 million for 2025, driven by strategic acquisitions and medical market expansion, despite a cybersecurity incident and labor issues.
Worse than expected
Delay expected
NASDAQ
UFP Technologies' 2024 annual report reveals a significant increase in net sales and profitability, fueled by strategic acquisitions and organic growth in key markets.
Better than expected
NASDAQ
UFP Technologies' annual 10-K filing provides a detailed overview of its common stock, corporate governance, and risk factors.
Better than expected

Insider Trading (Form 4)

See all →
NASDAQ
Symeria Hudson, a Director of Ufp Technologies Inc, sold 1,926 shares of common stock on August 14, 2026 for $324.58 per share.
NASDAQ
Cynthia L Feldmann, a Director of Ufp Technologies Inc, sold 1,000 shares of common stock on August 13, 2026 for $324.26 per share.
NASDAQ
Joseph John Hassett, a Director of Ufp Technologies Inc, reported multiple transactions in common stock on June 4, 2026.
NASDAQ
R Jeffrey Bailly, Executive Chairman and a Director of Ufp Technologies Inc, sold 13,011 shares of common stock on August 10, 2026.
NASDAQ
R Jeffrey Bailly, Executive Chairman and a Director of Ufp Technologies Inc, sold 15,695 shares of common stock on August 6, 2026.
NASDAQ
Jason Holt, Vice President of Ufp Technologies Inc, sold 1,100 shares of common stock on August 6, 2026 for $317.00 per share.

Proxy Statements (Def-14A)

NASDAQ
UFP Technologies announces its 2026 Annual Meeting of Stockholders will be a virtual event on June 4th, focusing on director elections, executive compensation, and auditor ratification.
NASDAQ
UFP Technologies will hold its annual stockholders meeting virtually on June 4, 2025, to vote on director elections, executive compensation, auditor ratification, and other business.
Better than expected
NASDAQ
UFP Technologies will hold its annual stockholders meeting virtually on June 5, 2024, to vote on director elections, executive compensation, and the ratification of its accounting firm.
Better than expected

Schedule 13G - Passive Investments

See all →
NASDAQ
Vanguard Capital Management has reported beneficial ownership of over 5% of UFP Technologies Inc. common stock.
NASDAQ
Wasatch Advisors LP has reported a significant increase in its beneficial ownership of UFP Technologies Inc. common stock, now holding 8.8% of the class.
NASDAQ
Neuberger Berman Group LLC and its affiliates have reported a beneficial ownership stake of 6.9% in UFP Technologies Inc., as of June 30, 2026.
NASDAQ
Congress Asset Management Company LLP has increased its beneficial ownership of UFP Technologies Inc. common stock to 5.4%, holding 416,762 shares as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, indicating it no longer holds beneficial ownership in UFP Technologies Inc. following an internal realignment.
NASDAQ
Wasatch Advisors LP has reported a 10.1% beneficial ownership stake in UFP Technologies Inc., holding 782,708 shares of common stock.